# Oxipital AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxipital-ai

- Industry: Industrial Machinery
- Headquarters: Bedford, US
- Website: www.oxipitalai.com/
- Latest round: Series A (Jul 8, 2026)
- Investors on record: 3

## About

Oxipital AI is a US-based company specializing in advanced AI machine vision systems. Its flagship product, the V-CORTX platform, enhances operational efficiency in manufacturing through real-time quality control and data insights. Founded in 2024 in Bedford, US, Oxipital AI focuses on integrating AI vision technology for manufacturers and machine builders. Mark Chiappetta serves as the CEO of the company. Oxipital AI specializes in advanced AI machine vision systems, primarily through its flagship product, the V-CORTX platform. This integrated AI vision platform empowers manufacturers and machine builders to implement and scale machine vision technology efficiently, addressing critical challenges in high-variability manufacturing environments. V-CORTX enables real-time product inspections and quality control, significantly enhancing operational efficiency and decision-making processes across various manufacturing sectors, particularly in the food industry. The platform utilizes a user-friendly web-based interface that allows clients to gain actionable insights through live dashboards, facilitating rapid deployment without the need for coding or extensive training data preparation. Oxipital AI’s solutions are employed by a diverse client base, including major food manufacturers and processors, and are marketed primarily in North America and Europe.Oxipital AI generates revenue through a business-to-business (B2B) model, primarily offering subscription-based access to its V-CORTX platform along with associated support services. The revenue structure includes partnerships with large-scale manufacturers who integrate the V-CORTX solution into their production lines for quality inspection and robotic guidance. Clients typically engage in transactions that involve annual licensing fees for software access, alongside potential costs for hardware like specialized cameras designed for food-grade environments. Specific pricing details for individual services and solutions are tailored to meet the needs of clients, often reflecting the scale and complexity of the deployment. The company’s revenue is further bolstered by the sale of custom solutions and ongoing maintenance services that ensure optimal system performance. In July 2026, Oxipital AI raised Series A funding co-led by investors SAS Private Equities and Scale Venture Partners, with participation from another investor Material Impact Fund. This funding will be utilized to enhance its AI capabilities. The company has plans for expanding its V-CORTX offerings and targeting new markets, particularly in North America and Europe, to increase its footprint in the manufacturing sector.

## Funding rounds

- Series A, Jul 8, 2026 — Scale Venture Partners, Material Impact Fund, SAS Private Equities

## Investors

- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series A
- Material Impact Fund (https://capitalatlas.ai/funds/material-impact-fund) — Series A
- SAS Private Equities — Series A